Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 98

Showing 26-50 of 98 citing articles:

Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Peter Holíček, Iva Truxová, Jana Raková, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
Hui Yuwen, Huajing Wang, Tengteng Li, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1680-1698
Open Access | Times Cited: 6
SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma
Shunli Feng, Wubin Yuan, Zhen Sun, et al.
Journal of Oral Pathology and Medicine (2022) Vol. 51, Iss. 7, pp. 620-629
Closed Access | Times Cited: 24
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification
Enrico Caliman, Sara Fancelli, Giulia Petroni, et al.
Lung Cancer (2022) Vol. 175, pp. 88-100
Open Access | Times Cited: 21
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
Adriana Petrazzuolo, Maria Chiara Maiuri, Laurence Zitvogel, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12
Reviewing the path to balance: mechanisms and management of hypertension associated with targeting vascular endothelium in cancer therapy
Fei Si, Xin Ma, Qian Liu, et al.
Hypertension Research (2025)
Closed Access
Animal models of disease: Achievements and challenges
José Manuel Bravo‐San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Methods in cell biology (2025), pp. xv-xxi
Closed Access
Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation
Yunduo Liu, Yanxia Zhang, Qin Xiang, et al.
European Journal of Pharmacology (2025), pp. 177343-177343
Closed Access
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer
Haowei Wang, Lei Cheng, Jian Chen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Immunotherapy Combined with Chemotherapy in the First-Line Treatment of Advanced Gastric Cancer: Systematic Review and Bayesian Network Meta-Analysis Based on Specific PD-L1 CPS
Wen‐Wei Zhang, Kaibo Guo, Song Zheng
Current Oncology (2025) Vol. 32, Iss. 2, pp. 112-112
Open Access
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Hashini Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 771-771
Open Access
Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy
Yufeng Guo, Rui Wan, Jianchun Duan, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: A systematic review and meta-analysis
F. Albano, Francesco Severini, Giovanni Calice, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167821-167821
Open Access
Role of m7G modification regulators as biomarkers in gastric cancer subtyping and precision immunotherapy
Fa Ling, Huolun Feng, Sifan Wu, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114594-114594
Closed Access
Impact of radiation therapy on the immunological tumor microenvironment
Emma Guilbaud, Flavie Naulin, Lydia Meziani, et al.
Cell chemical biology (2025)
Closed Access
A Totipotent “All‐In‐One” Peptide Sequentially Blocks Immune Checkpoint and Reverses the Immunosuppressive Tumor Microenvironment
Limin Zhang, Zhenqi Jiang, Xi Yang, et al.
Advanced Materials (2022) Vol. 35, Iss. 2
Closed Access | Times Cited: 18
Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells
Yingqi Liu, Xuemei Yao, Youbo Zhao, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113213-113213
Open Access | Times Cited: 10
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Vanessa Klapp, Aitziber Buqué, Norma Bloy, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
CD161 + CD127 + CD8 + T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
Jingjing Qu, Yuekang Li, Binggen Wu, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, et al.
Oncogene (2022) Vol. 41, Iss. 27, pp. 3511-3523
Open Access | Times Cited: 15
Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma
Jie Fu, Sixue Wang, Zhenghao Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14

Scroll to top